Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amita Gupta

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
The American Journal of Clinical Nutrition|September 27, 2025
Maternal anemia during pregnancy and its association with the gut microbiota profile in pregnant and postpartum women, and their infants: a cohort studyJenna Mandell, Laura E Caulfield, Sameera Talegawkar, et al.
Emerging Infectious Diseases|June 23, 2004
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001Amita Gupta, Jennifer M Nelson, Timothy J Barrett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
BMJ Open|April 7, 2022
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2017
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort StudyMark W Tenforde, Ashish Yadav, David W Dowdy, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
The American Journal of Clinical Nutrition|September 27, 2025
Maternal anemia during pregnancy and its association with the gut microbiota profile in pregnant and postpartum women, and their infants: a cohort studyJenna Mandell, Laura E Caulfield, Sameera Talegawkar, et al.
Emerging Infectious Diseases|June 23, 2004
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001Amita Gupta, Jennifer M Nelson, Timothy J Barrett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 4, 2016
Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy InitiationJyoti S Mathad, Nikhil Gupte, Ashwin Balagopal, et al.
BMJ Open|April 7, 2022
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)Meenu Bajpai, Ashish Maheshwari, Vikas Dogra, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2017
Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort StudyMark W Tenforde, Ashish Yadav, David W Dowdy, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2022
Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS TrialMandar S Paradkar, Bella Devaleenal D, Tisungane Mvalo, et al.
Pageof 33